adenosine monophosphate has been researched along with Alzheimer Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Archa Rajagopal, J; Chase Barton, C; Davis Sanders, O; Lopez, K; Lopez, O; Malik, F; Rajagopal, L | 1 |
| Guo, D; Huang, L; Ji, S; Jiang, Y; Ma, X; Wu, Y; Yu, L; Zhu, R | 1 |
| Cho, JY; Kim, B; Kim, H; Kim, HS | 1 |
| Goudarzi, I; Jafari, A; Rashtiani, S; Rohampour, K | 1 |
| Akolkar, H; Mandal, PK; Tripathi, M | 1 |
| Lebovics, R; Lesch, P; Sunderland, T; Wolozin, B | 1 |
1 review(s) available for adenosine monophosphate and Alzheimer Disease
| Article | Year |
|---|---|
Does oxidative DNA damage trigger histotoxic hypoxia via PARP1/AMP-driven mitochondrial ADP depletion-induced ATP synthase inhibition in Alzheimer's disease?
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Alzheimer Disease; DNA Damage; Humans; Hypoxia; Mitochondrial Proton-Translocating ATPases; NAD; Oxidative Stress; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases | 2022 |
5 other study(ies) available for adenosine monophosphate and Alzheimer Disease
| Article | Year |
|---|---|
Novel Phenylethanoid Glycosides Improve Hippocampal Synaptic Plasticity via the Cyclic Adenosine Monophosphate-CREB-Brain-Derived Neurotrophic Growth Factor Pathway in APP/PS1 Transgenic Mice.
Topics: Adenosine Monophosphate; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Hippocampus; Maze Learning; Mice; Mice, Transgenic; Nerve Growth Factor; Neuronal Plasticity | 2023 |
Nicotinamide attenuates the decrease in dendritic spine density in hippocampal primary neurons from 5xFAD mice, an Alzheimer's disease animal model.
Topics: Adenosine Monophosphate; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cells, Cultured; Dendritic Spines; Disease Models, Animal; Disease Progression; Female; Hippocampus; Lysophosphatidylcholines; Lysophospholipids; Male; Metabolomics; Mice, Transgenic; Mutation, Missense; Neurons; Niacinamide; Peptide Fragments; Point Mutation; Presenilin-1 | 2020 |
Adenosine monophosphate activated protein kinase (AMPK) is essential for the memory improving effect of adiponectin.
Topics: Adenosine Monophosphate; Adiponectin; Alzheimer Disease; AMP-Activated Protein Kinases; Animals; Disease Models, Animal; Male; Memory; Memory Disorders; Rats, Wistar; Signal Transduction | 2021 |
Mapping of hippocampal pH and neurochemicals from in vivo multi-voxel 31P study in healthy normal young male/female, mild cognitive impairment, and Alzheimer's disease.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Aged; Alzheimer Disease; Cognitive Dysfunction; Creatine Kinase, BB Form; Data Interpretation, Statistical; Female; Functional Laterality; Hippocampus; Humans; Hydrogen-Ion Concentration; Image Processing, Computer-Assisted; Lipid Peroxidation; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Phosphorus Isotopes; Reference Values | 2012 |
A.E. Bennett Research Award 1993. Olfactory neuroblasts from Alzheimer donors: studies on APP processing and cell regulation.
Topics: Adenosine Monophosphate; Adolescent; Adult; Aged; Alzheimer Disease; Amyloid beta-Protein Precursor; Biopsy; Cell Line; Cells, Cultured; Epithelium; Female; Growth Substances; Humans; Isoproterenol; Male; Middle Aged; Nasal Mucosa; Neurons; Olfactory Mucosa; Olfactory Nerve; Peptide Fragments; Theophylline | 1993 |